IS THERE AN AGE LIMIT TO LONGEVITY? WHEN IS IT TOO LATE TO INTERVENE?
Thumbnail from YouTube. Playing loads the YouTube player.
History & recommendationsOff
Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.
Open saved items & history →About this video
Creator description · original language
In this 123rd episode of Sober Head Podcast, Dr. Esra Çavuşoğlu, PhD welcomes Prof. Brian Kennedy.
In this episode, leading geroscientist Prof. Brian Kennedy explains how longevity science can move beyond academic laboratories and into responsible, real-world clinical practice. We explore mTOR and rapamycin, CA-AKG, biological age testing, ovarian aging, menopause-delaying research, peptides, gene therapies, and the growing longevity clinic industry.
Dr. Kennedy warns that combining too many supplements may unintentionally over-suppress essential cellular pathways. He also explains why many commercial biological age tests remain inconsistent, why personalized measurement matters, and how peptides could become some of the most important longevity medicines of the future.
We also discuss Singapore’s $300 million healthy longevity initiative and why healthcare must shift from treating disease to preserving health and performance throughout life.
#EsraÇavuşoğlu #AyıkKafa #ElevatingLifeEvolvingHealth #Longevilab #BrianKennedy
Prof. Brian Kennedy
Website: https://medicine.nus.edu.sg/sites/briankennedylab/?utm_source=chatgpt.com
https://www.prolon.com.tr/*10% off throughout August with the code AYIKKAFA10.
Special thanks to T.C. Istanbul Gedik University https://www.gedik.edu.tr/en/
Ayık Kafa · 2 min · Source published: 2026-08-08
Added to Harbor: 10/22/2026
Original on YouTube ↗Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.